These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21210227)
1. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. Chung MJ; Lee KJ; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB; Park JY Ann Surg Oncol; 2011 Jun; 18(6):1651-6. PubMed ID: 21210227 [TBL] [Abstract][Full Text] [Related]
2. The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer. Kang CM; Kim JY; Choi GH; Kim KS; Choi JS; Lee WJ; Kim BR J Surg Res; 2007 Jun; 140(1):31-5. PubMed ID: 17418869 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Hata S; Sakamoto Y; Yamamoto Y; Nara S; Esaki M; Shimada K; Kosuge T Ann Surg Oncol; 2012 Feb; 19(2):636-41. PubMed ID: 21863360 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [TBL] [Abstract][Full Text] [Related]
5. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer. Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352 [TBL] [Abstract][Full Text] [Related]
6. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
7. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063 [TBL] [Abstract][Full Text] [Related]
8. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311 [TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma. Veingerl B Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618 [TBL] [Abstract][Full Text] [Related]
11. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer]. Grotowski M Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811 [TBL] [Abstract][Full Text] [Related]
12. Biliary cystadenoma with elevated CA 19.9. Martín Parra JI; Rodríguez Sanjuán JC; Naranjo Gómez A Rev Esp Enferm Dig; 2002 Feb; 94(2):98-103. PubMed ID: 12185658 [TBL] [Abstract][Full Text] [Related]
13. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Berger AC; Meszoely IM; Ross EA; Watson JC; Hoffman JP Ann Surg Oncol; 2004 Jul; 11(7):644-9. PubMed ID: 15197014 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387 [TBL] [Abstract][Full Text] [Related]
15. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC). Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034 [TBL] [Abstract][Full Text] [Related]
16. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Park IJ; Choi GS; Lim KH; Kang BM; Jun SH Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600 [TBL] [Abstract][Full Text] [Related]
17. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Alexander-Sefre F; Chandrakumaran K; Banerjee S; Sexton R; Thomas JM; Moran B Colorectal Dis; 2005 Jul; 7(4):382-6. PubMed ID: 15932563 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139 [TBL] [Abstract][Full Text] [Related]
19. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]